Literature DB >> 21350874

Serum adenosine deaminase activity in patients with systemic lupus erythematosus: a study based on ADA1 and ADA2 isoenzymes pattern.

Reza Saghiri1, Niloufar Ghashghai, Shafieh Movaseghi, Pegah Poursharifi, Shohreh Jalilfar, Manijeh Ahmadi Bidhendi, Leila Ghazizadeh, Mina Ebrahimi-Rad.   

Abstract

Adenosine deaminase (ADA) plays a crucial role in the development and maintenance of normal immune system. So, any immunological imbalances could associate with its altered activity in serum. This study evaluated the activity of total ADA and its isoenzymes in serum of 45 patients with systemic lupus erythematosus (SLE). Included were 23 patients with active SLE, 22 during the inactive phase of the disease, and 45 healthy subjects. Our results provided evidence that the significantly elevated total ADA activity in serum of SLE patients is correlated mainly with the increased ADA2 level. The highest mean ADA2 activity during the relapse phase of the disease could be an indication to the macrophages, the main source of ADA2. It might be concluded that ADA and its isoenzymes analysis in serum of patients could be used as a useful and non-invasive diagnostic tool in evaluation of SLE active phase and the disease severity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21350874     DOI: 10.1007/s00296-011-1836-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  44 in total

1.  Autoantibodies to nuclear antigens: correlation between cytotoxicity and DNA-hydrolyzing activity.

Authors:  A V Kozyr; A V Kolesnikov; N A Zelenova; L P Sashchenko; S V Mikhalap; M E Bulina; A N Ignatova; P V Favorov; A G Gabibov
Journal:  Appl Biochem Biotechnol       Date:  2000 Jan-Mar       Impact factor: 2.926

2.  The evaluation of lipid peroxidation and adenosine deaminase activity in patients with Behçet's disease.

Authors:  K Köse; C Yazici; O Aşşioğlu
Journal:  Clin Biochem       Date:  2001-03       Impact factor: 3.281

3.  A reduced nicotinamide adenine dinucleotide--linked kinetic assay for adenosine deaminase activity.

Authors:  G Ellis; D M Goldberg
Journal:  J Lab Clin Med       Date:  1970-09

4.  Accelerated Fas-mediated apoptosis of monocytes and maturing macrophages from patients with systemic lupus erythematosus: relevance to in vitro impairment of interaction with iC3b-opsonized apoptotic cells.

Authors:  Y Shoshan; I Shapira; E Toubi; I Frolkis; M Yaron; D Mevorach
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

Review 5.  Role of apoptosis in autoimmunity.

Authors:  H M Lorenz; M Herrmann; T Winkler; U Gaipl; J R Kalden
Journal:  Apoptosis       Date:  2000-11       Impact factor: 4.677

6.  Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.

Authors:  Randa A K Mahmoud; Hala I El-Gendi; Hanan H Ahmed
Journal:  Clin Biochem       Date:  2005-02       Impact factor: 3.281

7.  Adenosine deaminase isoenzyme levels in patients with human T-cell lymphotropic virus type 1 and human immunodeficiency virus type 1 infections.

Authors:  I Tsuboi; K Sagawa; S Shichijo; M M Yokoyama; D W Ou; M D Wiederhold
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

8.  Adenosine deaminase activity in sera of patients with psoriasis, mycosis fungoides and adult T cell leukemia.

Authors:  H Koizumi; A Ohkawara
Journal:  Acta Derm Venereol       Date:  1992-11       Impact factor: 4.437

9.  Adenosine deaminase in patients with primary immunodeficiency syndromes: the analysis of serum ADA1 and ADA2 activities.

Authors:  Pegah Poursharifi; Reza Saghiri; Mina Ebrahimi-Rad; Habibollah Nazem; Zahra Pourpak; Mostafa Moin; Sedigheh Shams
Journal:  Clin Biochem       Date:  2008-11-08       Impact factor: 3.281

10.  Serum and synovial fluid adenosine deaminase activity in patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis.

Authors:  H Yuksel; T F Akoğlu
Journal:  Ann Rheum Dis       Date:  1988-06       Impact factor: 19.103

View more
  17 in total

Review 1.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

2.  No association between serum adenosine deaminase activity and disease activity in Crohn's disease.

Authors:  Mahmoud Sajjadi; Ali Gholamrezaei; Nasser Ebrahimi Daryani
Journal:  Dig Dis Sci       Date:  2015-02-05       Impact factor: 3.199

3.  Activation of CECR1 in M2-like TAMs promotes paracrine stimulation-mediated glial tumor progression.

Authors:  Changbin Zhu; Dana Mustafa; Ping-Pin Zheng; Marcel van der Weiden; Andrea Sacchetti; Maarten Brandt; Ihsan Chrifi; Dennie Tempel; Pieter J M Leenen; Dirk Jan Duncker; Caroline Cheng; Johan M Kros
Journal:  Neuro Oncol       Date:  2017-05-01       Impact factor: 12.300

4.  Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells.

Authors:  Yuliia Kaljas; Chengqian Liu; Maksym Skaldin; Chengxiang Wu; Qing Zhou; Yuanan Lu; Ivona Aksentijevich; Andrey V Zavialov
Journal:  Cell Mol Life Sci       Date:  2016-09-23       Impact factor: 9.261

5.  Serum adenosine deaminase activity is increased in systemic lupus erythematosus patients and correlated with disease activity.

Authors:  Zhao-Wei Gao; Guan-Hua Zhao; Zhe Zhang; Jing Huang; Zi-Yue Li; Hui-Zhong Zhang; Ke Dong
Journal:  Immunol Res       Date:  2018-04       Impact factor: 2.829

6.  Assessment of adenosine deaminase (ADA) activity and oxidative stress in patients with chronic tonsillitis.

Authors:  Mehmet Fatih Garca; Halit Demir; Mahfuz Turan; Nazım Bozan; Ahmet Kozan; Şeyda Bayel Belli; Ayşe Arslan; Hakan Cankaya
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-12-04       Impact factor: 2.503

7.  Relationship between serum adenosine deaminase levels and liver histology in autoimmune hepatitis.

Authors:  Murat Torgutalp; Cumali Efe; Hakan Babaoglu; Taylan Kav
Journal:  World J Gastroenterol       Date:  2017-06-07       Impact factor: 5.742

8.  Easy and non-invasive disease detection in pigs by adenosine deaminase activity determinations in saliva.

Authors:  Ana María Gutiérrez; Ernesto De La Cruz-Sánchez; Ana Montes; Juan Sotillo; Cándido Gutiérrez-Panizo; Pablo Fuentes; Pedro Luis Tornel; Juan Cabezas-Herrera
Journal:  PLoS One       Date:  2017-06-08       Impact factor: 3.240

9.  Changes in CD73, CD39 and CD26 expression on T-lymphocytes of ANCA-associated vasculitis patients suggest impairment in adenosine generation and turn-over.

Authors:  Lovis Kling; Urs Benck; Annette Breedijk; Lisa Leikeim; Marianne Heitzmann; Stefan Porubsky; Bernhard K Krämer; Benito A Yard; Anna-Isabelle Kälsch
Journal:  Sci Rep       Date:  2017-09-15       Impact factor: 4.379

Review 10.  The role of adenosinergic pathway in human autoimmune diseases.

Authors:  Ke Dong; Zhao-Wei Gao; Hui-Zhong Zhang
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.